Similar articles

• "What is in a name? That which we call a rose. By any other name would smell as sweet": towards resolving ambiguity in the TNM Classification for Lung Cancer.

  Goldstraw P. Goldstraw P. Lung Cancer. 2014 Jun;84(3):207-8. doi: 10.1016/j.lungcan.2014.03.014. Epub 2014 Mar 18. Lung Cancer. 2014. PMID: 24685308 No abstract available.
• Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet.

  Armstrong AJ, Antonarakis ES, Taplin ME, Kelly WK, Beltran H, Fizazi K, Dahut WL, Shore N, Slovin S, George D, Carducci MA, Corn P, Danila D, Dreicer R, Heath E, Rathkopf D, Liu G, Nanus D, Stein M, Smith MR, Sternberg C, Wilding G, Nelson PS, Halabi S, Kantoff P, Clarke NW, Evans CP, Heidenreich A, Mottet N, Gleave M, Morris MJ, Scher HI. Armstrong AJ, et al. Ann Oncol. 2018 Jan 1;29(1):23-25. doi: 10.1093/annonc/mdx648. Ann Oncol. 2018. PMID: 29088323 Free PMC article. No abstract available.
• What's in a name? That which we call a rose by any other name would smell as sweet.

  Sundt TM. Sundt TM. J Thorac Cardiovasc Surg. 2019 Jun;157(6):e323. doi: 10.1016/j.jtcvs.2019.01.064. Epub 2019 Feb 20. J Thorac Cardiovasc Surg. 2019. PMID: 30797589 No abstract available.
• Risk communication and decision-making in the prevention of invasive breast cancer.

  Partridge AH. Partridge AH. Breast. 2017 Aug;34 Suppl 1:S55-S57. doi: 10.1016/j.breast.2017.06.028. Epub 2017 Jul 8. Breast. 2017. PMID: 28690103 Review.
• Communicating shared decision-making: cancer patient perspectives.

  Thorne S, Oliffe JL, Stajduhar KI. Thorne S, et al. Patient Educ Couns. 2013 Mar;90(3):291-6. doi: 10.1016/j.pec.2012.02.018. Epub 2012 Mar 30. Patient Educ Couns. 2013. PMID: 22464665 Review.